WuXi Biologics' issued share capital increases due to option exercises

WuXi Biologics (Cayman) Inc. has disclosed a series of share option exercises resulting in an increase in its issued share capital from August 31 to September 5, 2025. The company's total issued shares grew from 4,071,440,456 to 4,080,896,256 within this period. On September 1, 2025, 270,900 new shares were issued at HK$1.88, representing 0.00665% of the existing shares.

Further exercises of share options continued through the week. On September 2, 38,500 new shares were issued at HK$1.56. Subsequent issuances included 134,000 shares at HK$3.49 on September 3, and 7,000 shares at HK$1.29 on September 4. The largest single event occurred on September 5, with 9,000,000 new shares issued at HK$1.29, accounting for 0.22105% of the existing shares prior to that specific event.

The company also disclosed shares repurchased for cancellation but not yet cancelled. As of July 8, 2025, 11,680,000 shares were repurchased at HK$25.6, and on July 9, 2025, an additional 11,500,000 shares were repurchased at HK$25.91. These repurchases represent 0.28688% and 0.28246% of the existing shares respectively, and are awaiting cancellation.